We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
from Part IV - Drug interactions in specific patient populations and special conditions
Published online by Cambridge University Press: 07 September 2009
Introduction
Epilepsy in the mentally retarded differs from epilepsy in the mentally normal patient in relation to etiology, seizure types, epilepsy syndromes, choice of antiepileptic drugs, identification of their side effects and treatment outcome. Consequently, a successful antiepileptic drug therapy is a demanding task in terms of choice of drug therapy, combinations of drugs and side effects in mentally retarded patients compared with mentally normal people. Adverse effects and interactions between different antiepileptic drugs are a potential risk in the presence of many and difficult-to-treat seizure types, leading to frequent polytherapy. There is also an increased risk of interactions between antiepileptic drugs and other drugs because of the increased incidence of co-morbidity among these patients.
In patients who are handicapped or mentally retarded, there is no evidence that pharmacokinetic drug interactions per se are quantitatively or qualitatively different from those seen in otherwise normal epilepsy patients. However, it is the context of the treatment of their epilepsy that puts a different emphasis on the potential for interactions. These patients are characterized by an increased incidence of co-morbidity that may require treatment with other medications. Their epilepsies are generally more refractory to treatment and antiepileptic drug combinations are more likely to be used. Also, central nervous system (CNS) toxicity of drugs may be more prominent in mentally retarded patients, and this may include neurotoxic pharmacodynamic interactions between antiepileptic drugs as well as pharmacodynamic interactions between antiepileptic drugs and other psychotropic drugs.
To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.
